212 related articles for article (PubMed ID: 26873133)
1. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
Al-Sweidi S; Morissette M; Di Paolo T
J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
[TBL] [Abstract][Full Text] [Related]
2. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Al-Sweidi S; Morissette M; Di Paolo T
J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptors and lesion-induced response of striatal dopamine receptors.
Al Sweidi S; Morissette M; Rouillard C; Di Paolo T
Neuroscience; 2013 Apr; 236():99-109. PubMed ID: 23357113
[TBL] [Abstract][Full Text] [Related]
5. Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.
Morissette M; Jourdain S; Al Sweidi S; Menniti FS; Ramirez AD; Di Paolo T
Neuropharmacology; 2007 Jun; 52(7):1509-20. PubMed ID: 17420033
[TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
[TBL] [Abstract][Full Text] [Related]
7. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Battaglia G; Busceti CL; Molinaro G; Biagioni F; Storto M; Fornai F; Nicoletti F; Bruno V
J Neurosci; 2004 Jan; 24(4):828-35. PubMed ID: 14749427
[TBL] [Abstract][Full Text] [Related]
8. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
D'Astous M; Mendez P; Morissette M; Garcia-Segura LM; Di Paolo T
Mol Pharmacol; 2006 Apr; 69(4):1492-8. PubMed ID: 16434614
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.
Al Sweidi S; Sánchez MG; Bourque M; Morissette M; Dluzen D; Di Paolo T
J Neuroendocrinol; 2012 Jan; 24(1):48-61. PubMed ID: 21790809
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.
Bourque M; Morissette M; Di Paolo T
Neuropharmacology; 2015 Aug; 95():343-52. PubMed ID: 25892506
[TBL] [Abstract][Full Text] [Related]
12. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
[TBL] [Abstract][Full Text] [Related]
13. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179
[TBL] [Abstract][Full Text] [Related]
15. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.
Morissette M; Le Saux M; D'Astous M; Jourdain S; Al Sweidi S; Morin N; Estrada-Camarena E; Mendez P; Garcia-Segura LM; Di Paolo T
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):327-38. PubMed ID: 17936613
[TBL] [Abstract][Full Text] [Related]
16. Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist.
D'Astous M; Morissette M; Di Paolo T
Neuropharmacology; 2004 Dec; 47(8):1180-8. PubMed ID: 15567427
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
[TBL] [Abstract][Full Text] [Related]
18. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
[TBL] [Abstract][Full Text] [Related]
19. Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Di Paolo T
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():27-38. PubMed ID: 25046277
[TBL] [Abstract][Full Text] [Related]
20. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
